Accelerated atheroma and anti-β2-glycoprotein I antibodies

Ross R . The pathogenesis of atherosclerosis: a perspective for the 1990s . Nature 1993; 362: 801-809 .

Harris EN , Gharavi AE , Hughes GRV . Anti-phospholipid antibodies . Clin Rheum Dis 1985; 11: 591-609 .

Hughes GRV , Harris EN , Gharavi AE . The anticardiolipin syndrome . J Rheumatol 1986; 13: 486-489 .

McNeil HP , Chesterman CN , Krilis SA . Immunology and clinical importance of antiphospholipid antibodies . Adv Immunol 1991; 49: 193-280 .

Harris EN , Gharavi AE , Boey ML et al. Anticardiolipin antibodies: detection by radioimunoassay and association with thrombosis in systemic lipus erythematosus . Lancet 1983; 2: 1211-1214 .

Wassermann A , Neisser A , Bruck C . Eine serodiagnostishe reaction bei syphilis . Dtsch Med Wochenschr 1906; 32: 745-746 .

Pangborn MC . A new serologically active phospholipid from beef heart . Proc Soc Exp Biol Med 1941; 48: 484-486 .

Pangborn MC . Isolation and purification of a serologically active phospholipid from beef heart . J Biol Chem 1942; 143: 247-256 .

Moore JE , Lutz WB . The natural history of systemic lupus erythematosus: an approach to its study through chronic biologic false positive reactors . J Chronic Dis 1955; 1: 297-316 .

Moore JE , Mohr CF . Biologically false positive serologic test for syphilis . J Am Med Assoc 1952; 150: 467-473 .

Mueller JF , Ratnoff O , Henile RW . Observations on the characteristics of an unusual circulating anticoagulant . J Lab Clin Med 1951; 38: 254-261 .

Laurell AB , Nilsson IM . Hypergamma-globulinaemia, circulating anticoagulant, and biologic false positive Wassermann reaction: a study of two cases . J Lab Clin Med 1957; 49: 694-707 .

Conley CL , Hartmann RC . A hemorrhagic disorder caused by circulating anticoagulants in patients with disseminated lupus erythematosus . J Lab Clin Med 1952; 31: 621-622 .

Feinstein DI , Rapaport SI . Acquired inhibitors of blood coagulation . Prog Hemost Thromb 1972; 1: 75-95 .

Koike T , Sueishi M , Funaki H , Tomioka H , Yoshida S . Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus . Clin Exp Immunol 1984; 56: 193-199 .

McNeil HP , Simpson RJ , Chesterman CN , Krilis SA . Anti-phospho-lipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: b2-glycoprotein I (apolipoprotein H) . Proc Natl Acad Sci USA 1990; 87: 4120-4124 .

Galli M , Comfurius P , Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor . Lancet 1990; 335: 1544-1547 .

Matsuura E , Igarashi Y , Fujimoto M , Ichikawa K , Koike T . Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease . Lancet 1990; 336: 177-178 .

Matsuura E , Igarashi Y , Fujimoto M et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor . J Immunol 1992; 148: 3885-3891 .

Hunt JE , McNeil HP , Morgan GJ , Crameri RM , Krilis SA . A phospholipid-b2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection . Lupus 1992; 1: 75-81 .

Matsuura E , Igarashi Y , Yasuda T , Triplett DA , Koike T . Anticardiolipin antibodies recognize b2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface . J Exp Med 1994; 179: 457-462 .

Roubey RAS . Immunology of the antiphospholipid antibody syndrome . Arthritis Rheum 1996; 39: 1444-1454 .

Sheng Y , Kandiah DA , Krilis SA . Anti-b2-glycoprotein I autoantibodies from patients with the “antiphospholipid” syndrome bind to b2-glycoprotein I with low affinity: dimerization of b2-glycoprotein I induces a significant increase in anti-b2-glycoprotein I antibody affinity . J Immunol 1998; 161: 2038-2043 .

Wang MX , Kandiah DA , Ichikawa K et al. Epitope specificity of monoclonal anti-b2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome . J Immunol 1995; 155: 1629-1636 .

Iverson GM , Victoria EJ , Marquis DM . Anti-b2-glycoprotein I (b2-GPI) autoantibodies recognize an epitope on the first domain of b2-GPI . Proc Natl Acad Sci USA 1998; 95: 15542-15546 .

Berden JH , Hang LM , McConahey PJ , Dixon FJ . Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities . J Immunol 1983; 130: 1699-1705 .

Hang LM , Izui S , Dixon FJ . (NZW6BXSB) F1 hybrid . A model of acute lupus and coronary vascular disease with myocardial infarction . J Exp Med 1981; 154: 216-221 .

Hashimoto Y , Kawamura M , Ichikawa K et al. Anti-cardiolipin antibodies in NZW6Bxsb F1 mice: a model of antiphospholipid syndrome . J Immunol 1992; 149: 1063-1068 .

Ichikawa K , Khamashta MA , Koike T , Matsuura E , Hughes GRV . b2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome . Arthritis Rheum 1994; 37: 1453-1461 .

Ichikawa K , Tsutsumi A , Atsumi T et al. A chimeric antibody with human g1 constant region as a putative standard for assays to detect IgG b2-glycoprotein I (b2-GPI) dependent anticardiolipin and anti-b2-GPI antibodies . Arthritis Rheum 1999; 42: 2461-2470 .

Schultze HE , Heide K , Haupt H . Uber ein bisher ubekanntes niedermolekulars b2-Globulin des Hamanserums . Naturwissenschaften 1961; 48: 719-724 .

Wurm H . Beta2-glycoprotein I (apolipoprotin H) interactions with phospholipid vesicles . Int J Biochem 1984; 16: 511-515 .

Polz E . Isolation of a specific lipid-binding protein from human serum by affinity chromatography using heparin-Sepharose. In: Peeters H (ed.) Protides of Biological Fluids Pergamon Press, Oxford , 1979, p. 817-817.

Polz E , Kostner GM . The binding of b2-glycoprotein I to human serum lipoproteins: distribution among density fractions . FEBS Lett 1979; 102: 183-186 .

Nimp J , Bevers EM , Bomans PH et al. Prothrombinase activity of human platelets is inhibited by b2-glycoprotein I . Biochim Biophys Acta 1986; 884: 142-149 .

Schousboe I . b2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway . Blood 1985; 66: 1086-1091 .

Nimpf J , Wurm H , Kostner GM . b2-glycoprotein I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation . Atherosclerosis 1987; 63: 109-114 .

Ieko M , Ichikawa K , Triplett DA et al. b2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies . Arthritis Rheum 1999; 42: 167-174 .

Lozier J , Takahashi N , Putnam FW . Complete amino acid sequence of human plasma b2-glycoprotein I . Proc Natl Acad Sci USA 1984; 81: 3640-3644 .

Kato H , Enjyuoji K . Amino acid sequence and location of the disulfide bonds in bovine b2-glycoprotein I: The presence of five sushi domains . Biochemistry 1991; 30: 11687-11694 .

Matsuura E , Igarashi M , Igarashi Y et al. Molecular definition of human b2-glycoprotein I (b2-GPI) by cDNA cloning and inter-species differences of b2-GPI in alternation of anticardiolipin binding . Int Immunol 1991; 3: 1217-1221 .

Steinkasserer A , Estaller C , Weiss EH , Sim RB , Day AJ . Complete nucleotide and deduced amino acid sequence of human beta2-glycoprotein I . Biochem J 1991; 277: 387-391 .

Mehdi H , Nunn M , Steel DM et al. Nucleotide sequence and expression of the human gene encoding apolipoprotein H (b2-glycoprotein I) . Gene 1991; 108: 293-298 .

Steinkasserer A , Barlow PN , Willis AC et al. Activity, disulphide mapping and structural modelling of the fifth domain of human b2-glycoprotein I . FEBS Lett 1992; 313: 193-197 .

Hunt JE , Krilis SA . The fifth domain of b2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognize by anticardiolipin antibodies . J Immunol 1994; 152: 653-659 .

Matsuura E , Igarashi M , Igarashi Y et al. Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on b2-glycoprotein I structure recognized by anticardiolipin antibodies . Lupus 1995; 4 (Suppl 1): S13-S17 .

Sheng Y , Sali A , Herzog H , Lahnstein J , Krilis SA . Site-directed mutagenesis of recombinant human b2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity . J Immunol 1996; 157: 3744-3751 .

Hunt JE , Simpson RJ , Krilis SA . Identification of a region of b2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity . Proc Natl Acad Sci USA 1993; 90: 2141-2145 .

Ohkura N , Hagihara Y , Yoshimura T , Goto Y , Kato H . Plasmin can reduce the function of human b2 glycoprotein I by cleaving domain V into a nicked form . Blood 1998; 91: 4173-4179 .

Kamboh MI , Ferrell RE , Sepehrnia B . Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (b2-glycoprotein-I) . Am J Hum Genet 1988; 42: 452-457 .

Kamboh MI , Ferrell RE . Apolipoprotein H polymorphism and its role in lipid metabolism . Adv Lipid Res 1991; 1: 9-18 .

Sanghera DK , Kristensen T , Hamman RF , Kamboh MI . Molecular basis of the apolipoprotein H (b2-glycoprotein I) protein polymorphism . Hum Gent 1997; 100: 57-62 .

Norman DG , Barlow PN , Baron M et al. Three-dimensional structure of a complement control protein module in solution . J Mol Biol 1991; 219: 717-725 .

Igarashi M , Matsuura E , Igarashi Y et al. Human b2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system . Blood 1996; 87: 3262-3270 .

Bouma B , de Goot PG , van den Elsen JMH et al. Adhesion mechanism of human b2-glycoprotein I to phospholipids based on its crystal structure . EMBO J 1999; 18: 5166-5174 .

Del Papa N , Guidali L , Spatola L et al. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: b2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules . Clin Exp Rheumatol 1995; 13: 179-185 .

Simantov R , LaSala JM , Lo SK et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies . J Clin Invest 1995; 96: 2211-2219 .

Palinski W , Rosenfeld ME , Yla-Herttuala S et al. Low density lipoprotein undergoes oxidative modification in vivo . Proc Natl Acad Sci USA 1989; 86: 1372-1376 .

Palinski W , Yla-Harttuala S , Rosenfeld ME et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein . Atherosclerosis 1990; 10: 325-335 .

Salonen JT , Yla-Harttuala S , Yamamoto R et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis . Lancet 1992; 339: 883-887 .

Puurunen M , Vaarala O , Julkunen H , Aho K , Palosuo T . Antibodies to phospholipid binding proteins and occurrence of thrombosis in patients with systemic lupus erythematosus . Clin Immununol Immunopathol 1996; 80: 16-22 .

Vaarala O , Alfthan G , Jauhiainen M et al. Crossreaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus . Lancet 1993; 341: 923-925 .

Romero FI , Amengual O , Atsumi T et al. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-b2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein . Br J Rheumatol 1998; 37: 883-888 .

Hasunuma Y , Matsuura E , Makita Z et al. Involvement of b2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages . Clin Exp Immunol 1997; 107: 569-573 .

Horkko S , Miller E , Dudl E et al. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein . J Clin Invest 1996; 98: 815-825 .

Horkko S , Miller E , Branch DW , Palinski W , Witztum JL . The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and b2-glycoprotein I (and other proteins) . Proc Natl Acad Sci USA 1997; 94: 10356-10361 .

Horkko S , Bird DA , Miller E et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins . J Clin Invest 1999; 103: 117-128 .

Blank M , Faden D , Tincani A et al. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice . J Autoimmun 1994; 7: 441-455 .

Garcia CO , Kanbour-Shakir A , Tang H et al. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI . Am J Reprod Immunol 1997; 37: 118-124 .

George J , Afek A , Gilburd B et al. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized b2-glycoprotein I . Circulation 1988; 98: 1108-1115 .

George J , Harats D , Gilburd B et al. Immunocalizationof b2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression . Circulation 1999; 9: 2227-2230 .